Crossmark

Pharmaceutical Care Network Europe (PCNE) drug-related problem classification version 9.00: German translation and validation

Published Online: 2020-10-06

Published Print: 2021-06

Authors

Schindler, Elisabeth

Richling, Ina

Rose, Olaf https://orcid.org/0000-0003-1681-4909
License Information

Text and Data Mining valid from 2020-10-06

Version of Record valid from 2020-10-06
More Information

Article History

Received: 22 June 2020

Accepted: 9 September 2020

First Online: 6 October 2020

Conflicts of interest

: Elisabeth Schindler declares no conflict of interest. Ina Richling has received a speaker honorarium from Tilray, Gehe, Dr. Pöhnl, Univadis, Hexal, KWHC, Bionorica and Pfizer. Olaf Rose has received a speaker honorarium from AbbVie, MSD Sharp & Dohme, Novartis and Omnicell.

Document is current